PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Successful MPSVI Safety Review and PARA OA 008 Update, page-42

  1. 1,576 Posts.
    lightbulb Created with Sketch. 628
    Great work in deconvoluting that paragraph. The use of the word 'but' really grates. In your interpretation it makes a whooooole lot more sense if its flipped:

    "The 6 month timepoint will include imaging/MRI data so will provide a further complete insight to the DMOAD capabilities of the drug. However, the Company is hopeful for positive trends in the biomarker/WOMAC data at the interim readout at Day 56."

    Last edited by Torpy: 26/09/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.